5AM Ventures — 2016 Investments
4 investments dated 2016 · listed companies and verified rows first · show all
IDEAYA is a precision medicine oncology company developing first-in-class targeted therapies and rational drug combinations for molecularly defined, hard-to-treat cancers.
BiotechDigital HealthHealthtechMedical DevicesSouth San Francisco, US
Yujiro Hata(Executive Officer, Director)Paul Stone(Executive Officer)in
BoardTimothy Shannon(Director)inTerry Rosen(Director)Jeffrey Stein(Director)
Board seatJohn DiekmanBrian Daniels· per SEC Form D
Co-investorsCanaan PartnersNextech Invest
BiotechCambridge, US
G. Houston Hall(Manager of the Issuer)Adrian Z. Stecyk(Manager of the Issuer)Mark J. Pykett(Manager of the Issuer)
BoardAlexander M. Seaver(Manager of the Issuer)
Board seatArthur Tzianabos· per SEC Form D · $5M raise · filed Feb 2016
La Jolla, US
Richa Nand(Executive Officer)Alan Glicklich(Executive Officer)Mark Saad(Executive Officer)Paul A. Grayson(Executive Officer, Director)Erik Karrer(Executive Officer)Ray Stevens(Director)
Board seatAndrew J. Schwab· per SEC Form D
Co-investorsSR One Capital Management
Pioneering the development of prescription digital therapeutics.
HealthtechBoston, US
Corey McCann(Executive Officer, Director)Antoun Nabhan(Executive Officer)Christopher Guiffre(Executive Officer)
BoardAndrew Schwab(Director)inTimothy Petersen(Director)inZack Lynch(Director)in
Board seatAndrew J. Schwab· per SEC Form D · $20.4M raise · filed Feb 2016
Co-investorsJAZZ Venture PartnersArboretum VenturesGeneral CatalystOCA VenturesSeyen CapitalSoftBank Group+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.